Table 3 EQ-5D results, numbers and percentages of patients reporting problems in different dimensions at the last follow-up (median 5.3 years, IQR 3.8–7.2 years), by treatment groups, intention-to-treat analysis
EQ5D dimension | ECPR-based (n = 34) | CCPR (n = 26) | P value* |
|---|---|---|---|
Mobility | |||
Level 1 | 21 (61.7%) | 17 (65.4%) | |
Level 2 | 6 (17.6%) | 3 (11.5%) | 1 |
Level 3 | 4 (11.8%) | 3 (11.5%) | |
Level 4 | 3 (8.8%) | 3 (11.5%) | |
Level 5 | 0 | 0 | |
Self-Care | |||
Level 1 | 28 (82.3%) | 21 (80.8%) | |
Level 2 | 3 (8.8%) | 2 (7.7%) | 0.79 |
Level 3 | 2 (5.9%) | 2 (7.7%) | |
Level 4 | 1 (2.9%) | 1 (3.8%) | |
Level 5 | 0 | 0 | |
Usual activity | |||
Level 1 | 25 (73.5%) | 21 (80.8%) | |
Level 2 | 3 (8.8%) | 0 | 0.96 |
Level 3 | 3 (8.8%) | 4 (15.4%) | |
Level 4 | 3 (8.8%) | 1 (3.8%) | |
Level 5 | 0 | 0 | |
Pain/discomfort | |||
Level 1 | 18 (52.9%) | 17 (65.4%) | |
Level 2 | 10 (29.4%) | 7 (26.9%) | 0.34 |
Level 3 | 4 (11.8%) | 2 (7.7%) | |
Level 4 | 2 (5.9%) | 0 | |
Level 5 | 0 | 0 | |
Anxiety/depression | |||
Level 1 | 24 (70.6%) | 22 (84.6%) | |
Level 2 | 7 (20.6%) | 2 (7.7%) | 0.96 |
Level 3 | 3 (8.8%) | 2 (7.7%) | |
Level 4 | 0 | 0 | |
Level 5 | 0 | 0 | |